A federal judge has blocked the National Institutes of Health from implementing a policy to set a 15% indirect cost rate on grants, causing challenges and backlash. The decision affects medical research funding and innovation.
Key Points
Federal judge blocks NIH policy of setting a 15% indirect cost rate on grants
Challenges and legal battles play out in court affecting medical research
Decision impacts research funding and innovation in the medical field
Pros
Effort to ensure more funds go towards direct scientific research costs
Discussion around the best allocation of NIH grants
Cons
Disruption to medical research and treatment due to policy challenges
Backlash and opposition from various states and entities